DC5193Roxadustat(FG-4592)
Roxadustat (FG-4592) is an oral hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor developed for the treatment of anemia.
View activity & prices4 products · Page 1 of 1
All small molecule research tools
DC5193Roxadustat (FG-4592) is an oral hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor developed for the treatment of anemia.
View activity & prices
DC10474GBT 440 (Voxelotor) is an orally bioavailable modulator of sickle cell hemoglobin.
View activity & prices
DC8188Daprodustat (GSK1278863) is an orally active hypoxia-inducible factor prolyl hydroxylase inhibitor being developed for the treatment of anemia associated with chronic kidney disease.
View activity & prices
DC8166Molidustat (BAY 85-3934) is a novel inhibitor of hypoxia-inducible factor prolyl hydroxylase (HIF-PH) with mean IC50 values of 480 nM for PHD1, 280 nM for PHD2, and 450 nM for PHD3.
View activity & prices